NanoHive Medical
United States
- Woburn, Massachusetts
- 06/08/2024
- Series C
- $7,000,000
NanoHive Medical (formerly HD LifeSciences) created the proprietary, biomimetic Soft Titanium technology, which clearly distinguishes their products in the $1.9B spinal interbody fusion device market. The Hive™ portfolio of interbody fusion devices provides surgeons and their patients with the ideal features that lead to consistently strong fusion constructs and efficacious clinical experiences.
- Industry Medical Equipment Manufacturing
- Website https://nanohive.com/
- LinkedIn https://www.linkedin.com/company/nanohivemedical/
Related People
Patrick O.Founder
United States -
Greater Boston
Medical Device and Biosurgery executive leader with over 25 years of consistently successful experience at pre-commercial and commercial stages companies. Success in the medical device, orthobiologics, and biomaterials industries with technologies in the orthopedic, spine, neurosurgery, sports medicine, interventional radiology markets. Extensive team-building, executive management, strategy development, sales and marketing management, strategic partnership development, distribution channel development, Board management, start-up, turn around, and fund raising (over $90M) experience.
Uptool | $6,000,000 | (Feb 10, 2026)
BotGauge AI | $2,000,000 | (Feb 10, 2026)
Linkup(US) | $10,000,000 | (Feb 10, 2026)
Phylo | $13,500,000 | (Feb 10, 2026)
pHathom Technologies, Inc | $4,000,000 | (Feb 10, 2026)
microsynetics GmbH | $10,000,000 | (Feb 10, 2026)
Modveon | $10,000,000 | (Feb 10, 2026)
Qontext | $2,700,000 | (Feb 10, 2026)
Bound | $24,500,000 | (Feb 10, 2026)
Sentra(US) | $5,000,000 | (Feb 10, 2026)
Nixtla | $16,000,000 | (Feb 6, 2026)
Advance | $8,550,000 | (Feb 6, 2026)